The case for early intervention in rheumatoid arthritis.
A case for early intervention in rheumatoid arthritis is presented on the basis of the following observations: (1) established rheumatoid arthritis of 5 years duration or more is a progressive disease in most patients; (2) most patients with rheumatoid arthritis already have evidence of permanent radiographic damage within the first 2 years of disease; (3) the morbidity and mortality of rheumatoid arthritis are predicted by baseline data indicating more severe clinical status, rather than drug toxicity or causes 'unrelated' to rheumatoid arthritis; (4) currently used therapies, even those documented to be effective in randomized controlled trials, are not effective in most patients over periods of 2 years or longer. It is not known whether earlier intervention will result in better outcomes. However, these phenomena suggest a need for studies to evaluate early aggressive intervention in rheumatoid arthritis.
Pincus
T
T
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.
D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D005260:Female; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009017:Morbidity; D010396:Penicillamine / Q000627:therapeutic use; D016019:Survival Analysis
D000962:Antimalarials; D006046:Gold; D010396:Penicillamine